{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:37:41Z","timestamp":1786541861123,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Weifang City Youth Talent Lifting Project"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    This study aimed to develop and validate a clinical prediction model for the success of the focused ultrasound ablation system (FUAS) in treating adenomyosis. A retrospective analysis was conducted on 250 patients from Qingdao Women and Children\u2019s Hospital (2019\u20132022). Patients were categorized into success (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009108) or failure (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009142) groups based on a post-treatment lesion ablation rate greater than 80%. The dataset was split into training (70%) and validation (30%) sets. The multivariable analysis identified age (OR\u2009=\u20091.10,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.014), depth of adenomyosis (OR\u2009=\u20091.03,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.036), and uterine body (OR\u2009=\u20090.25,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.027) as independent predictors of FUAS efficacy, which were used to build the model. In the training set, the model achieved an AUC of 0.74 for efficacy prediction. The Bootstrap ROC indicates an AUC mean of 0.751 with a standard deviation of 0.036. In conclusion, a model based on age, depth of ademyosis, and uterine body lesions treatment dose accurately predicts FUAS success for adenomyosis. This tool can aid clinical decision-making and promote personalized treatment.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-48587-z","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:45:24Z","timestamp":1780389924000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of a clinical prediction model for the success of focused ultrasound ablation system for the treatment of adenomyosis"],"prefix":"10.1038","volume":"16","author":[{"given":"Limei","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changmei","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"issue":"5","key":"48587_CR1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.fertnstert.2023.03.018","volume":"119","author":"P Vercellini","year":"2023","unstructured":"Vercellini, P. et al. Association of endometriosis and adenomyosis with pregnancy and infertility. Fertil. Steril. 119(5), 727\u201340 (2023).","journal-title":"Fertil. Steril."},{"issue":"5","key":"48587_CR2","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.fertnstert.2023.03.006","volume":"119","author":"SE Bulun","year":"2023","unstructured":"Bulun, S. E. et al. Endometriosis and adenomyosis: Shared pathophysiology. Fertil. Steril. 119(5), 746\u201350 (2023).","journal-title":"Fertil. Steril."},{"issue":"5","key":"48587_CR3","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s10815-022-02476-2","volume":"39","author":"G Moawad","year":"2022","unstructured":"Moawad, G. et al. Adenomyosis and infertility. J. Assist. Reprod. Genet. 39(5), 1027\u201331 (2022).","journal-title":"J. Assist. Reprod. Genet."},{"issue":"22","key":"48587_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/ZDEG6110","volume":"26","author":"J Daniels","year":"2022","unstructured":"Daniels, J. et al. Uterine artery embolisation versus myomectomy for premenopausal women with uterine fibroids wishing to avoid hysterectomy: The FEMME RCT. Health Technol. Assess. 26(22), 1\u201374 (2022).","journal-title":"Health Technol. Assess."},{"issue":"6","key":"48587_CR5","first-page":"417","volume":"45","author":"ES Dason","year":"2023","unstructured":"Dason, E. S. et al. Guideline 437: Diagnosis and Management of Adenomyosis. Journal of obstetrics and gynaecology Canada: JOGC\u2009=\u2009Journal d\u2019obstetrique et gynecologie du. Can. : JOGC. 45 (6), 417\u201329e1 (2023).","journal-title":"Can. : JOGC"},{"issue":"1","key":"48587_CR6","first-page":"33","volume":"105","author":"S Schrager","year":"2022","unstructured":"Schrager, S., Yogendran, L., Marquez, C. M. & Sadowski, E. A. Adenomyosis: Diagnosis and management. Am. Fam. Physician 105(1), 33\u20138 (2022).","journal-title":"Am. Fam. Physician"},{"issue":"1","key":"48587_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/humrep\/dead206","volume":"39","author":"P Vercellini","year":"2024","unstructured":"Vercellini, P. et al. Proposal for targeted, neo-evolutionary-oriented secondary prevention of early-onset endometriosis and adenomyosis. Part II: Medical interventions. Hum. Reprod. 39(1), 18\u201334 (2024).","journal-title":"Hum. Reprod."},{"issue":"2","key":"48587_CR8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1001\/jama.2020.26436","volume":"326","author":"KA Kho","year":"2021","unstructured":"Kho, K. A., Chen, J. S. & Halvorson, L. M. Diagnosis, evaluation, and treatment of adenomyosis. Jama 326(2), 177\u2013178 (2021).","journal-title":"Jama"},{"key":"48587_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/biom14010032","author":"M Habiba","year":"2023","unstructured":"Habiba, M., Guo, S. W. & Benagiano, G. Are adenomyosis and endometriosis phenotypes of the same disease process?. Biomolecules https:\/\/doi.org\/10.3390\/biom14010032 (2023).","journal-title":"Biomolecules"},{"issue":"5","key":"48587_CR10","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1002\/jmri.28943","volume":"59","author":"Y Tang","year":"2024","unstructured":"Tang, Y. et al. Magnetic resonance imaging-based classification systems for informing better outcomes of adenomyosis after ultrasound-guided high-intensity focused ultrasound ablating surgery. J. Magn. Reson. Imaging 59(5), 1787\u201397 (2024).","journal-title":"J. Magn. Reson. Imaging"},{"key":"48587_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.688264","volume":"9","author":"LL Pang","year":"2021","unstructured":"Pang, L. L. et al. Efficacy of high-intensity focused ultrasound combined with GnRH-a for adenomyosis: A systematic review and meta-analysis. Front. Public Health 9, 688264 (2021).","journal-title":"Front. Public Health"},{"key":"48587_CR12","volume":"20","author":"SN Bahutair","year":"2024","unstructured":"Bahutair, S. N. & Alhubaishi, L. Y. High-intensity focused ultrasound in adenomyosis treatment: Insights on safety, efficacy, and reproductive prospects. Womens Health 20, 17455057241295593 (2024).","journal-title":"Womens Health"},{"issue":"12","key":"48587_CR13","doi-asserted-by":"publisher","DOI":"10.1177\/0300060520976492","volume":"48","author":"W Li","year":"2020","unstructured":"Li, W. et al. Clinical effectiveness and potential long-term benefits of high-intensity focused ultrasound therapy for patients with adenomyosis. J. Int. Med. Res. 48(12), 300060520976492 (2020).","journal-title":"J. Int. Med. Res."},{"key":"48587_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2023.102433","volume":"92","author":"Y Chen","year":"2024","unstructured":"Chen, Y. et al. Systematic review and meta-analysis of reproductive outcomes after high-intensity focused ultrasound (HIFU) treatment of adenomyosis. Best Pract. Res. Clin. Obstet. Gynaecol. 92, 102433 (2024).","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"48587_CR15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.actbio.2022.07.056","volume":"150","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. Genetically engineered bacteria-mediated multi-functional nanoparticles for synergistic tumor-targeting therapy. Acta Biomater. 150, 337\u2013352 (2022).","journal-title":"Acta Biomater."},{"issue":"1","key":"48587_CR16","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1186\/s12951-024-02868-9","volume":"22","author":"L Ren","year":"2024","unstructured":"Ren, L. et al. US\/PA\/MR multimodal imaging-guided multifunctional genetically engineered bio-targeted synergistic agent for tumor therapy. J. Nanobiotechnol. 22 (1), 615 (2024).","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"48587_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41582-020-00418-z","volume":"17","author":"Y Meng","year":"2021","unstructured":"Meng, Y., Hynynen, K. & Lipsman, N. Applications of focused ultrasound in the brain: From thermoablation to drug delivery. Nat. Rev. Neurol. 17(1), 7\u201322 (2021).","journal-title":"Nat. Rev. Neurol."},{"key":"48587_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2021.663128","volume":"8","author":"MJ Yang","year":"2021","unstructured":"Yang, M. J., Yu, R. Q., Chen, W. Z., Chen, J. Y. & Wang, Z. B. A prediction of NPVR\u2009\u2265\u200980% of ultrasound-guided high-intensity focused ultrasound ablation for uterine fibroids. Front. Surg. 8, 663128 (2021).","journal-title":"Front. Surg."},{"key":"48587_CR19","doi-asserted-by":"crossref","unstructured":"Gong, X. et al. Physician experience in technical success of achieving NPVR\u2009\u2265\u200980% of high-intensity focused ultrasound ablation for uterine fibroids: a multicenter study. Front. Med. Technol.\u00a03 2021. (2022).","DOI":"10.3389\/fmedt.2021.790956"},{"issue":"5","key":"48587_CR20","doi-asserted-by":"publisher","DOI":"10.1177\/03000605221102087","volume":"50","author":"X Gong","year":"2022","unstructured":"Gong, X. et al. Evaluation of physician experience in achieving non-perfused volume ratio of high-intensity focused ultrasound ablation for uterine fibroids: A multicentre study. J. Int. Med. Res. 50(5), 03000605221102087 (2022).","journal-title":"J. Int. Med. Res."},{"issue":"1","key":"48587_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-024-03093-0","volume":"24","author":"S Li","year":"2024","unstructured":"Li, S. et al. Achieving NPVR\u2009\u2265\u200980% as technical success of high-intensity focused ultrasound ablation for uterine fibroids: A cohort study. BMC Womens Health 24(1), 294 (2024).","journal-title":"BMC Womens Health"},{"key":"48587_CR22","doi-asserted-by":"crossref","unstructured":"Pados, G. et al. Adenomyosis and Infertility: A Literature Review. Med. (Kaunas Lithuania) 59(9). (2023).","DOI":"10.3390\/medicina59091551"},{"issue":"3","key":"48587_CR23","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.fertnstert.2020.12.010","volume":"115","author":"P Pirtea","year":"2021","unstructured":"Pirtea, P., Cicinelli, E., De Nola, R., de Ziegler, D. & Ayoubi, J. M. Endometrial causes of recurrent pregnancy losses: Endometriosis, adenomyosis, and chronic endometritis. Fertil. Steril. 115(3), 546\u201360 (2021).","journal-title":"Fertil. Steril."},{"issue":"23","key":"48587_CR24","doi-asserted-by":"publisher","first-page":"4588","DOI":"10.1111\/bph.15657","volume":"178","author":"F Zobdeh","year":"2021","unstructured":"Zobdeh, F. et al. Pharmacological treatment of migraine: Drug classes, mechanisms of action, clinical trials and new treatments. Br. J. Pharmacol. 178(23), 4588\u2013607 (2021).","journal-title":"Br. J. Pharmacol."},{"key":"48587_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1261801","volume":"14","author":"L Foster","year":"2023","unstructured":"Foster, L. et al. Identification of algal rich microbial blooms in the Sellafield Pile Fuel Storage Pond and the application of ultrasonic treatment to control the formation of blooms. Front. Microbiol. 14, 1261801 (2023).","journal-title":"Front. Microbiol."},{"issue":"1","key":"48587_CR26","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2024.2384471","volume":"41","author":"Y Dai","year":"2024","unstructured":"Dai, Y. et al. Evaluation of the therapeutic efficacy of high-intensity focused ultrasound ablation combined with different drugs in the treatment of adenomyosis. Int. J. Hyperthermia 41(1), 2384471 (2024).","journal-title":"Int. J. Hyperthermia"},{"key":"48587_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13111883","author":"L Moraru","year":"2023","unstructured":"Moraru, L. et al. Adenomyosis and its possible malignancy: A review of the literature. Diagnostics (Basel) https:\/\/doi.org\/10.3390\/diagnostics13111883 (2023).","journal-title":"Diagnostics (Basel)"},{"issue":"5","key":"48587_CR28","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.fertnstert.2023.01.041","volume":"119","author":"S Yildiz","year":"2023","unstructured":"Yildiz, S. et al. Adenomyosis: Single-cell transcriptomic analysis reveals a paracrine mesenchymal-epithelial interaction involving the WNT\/SFRP pathway. Fertil. Steril. 119(5), 869\u201382 (2023).","journal-title":"Fertil. Steril."},{"issue":"1","key":"48587_CR29","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2025.2468766","volume":"42","author":"Z Liu","year":"2025","unstructured":"Liu, Z., Liu, Z., Wan, X., Wang, Y. & Huang, X. Prediction of clinical outcome for high-intensity focused ultrasound ablation of adenomyosis based on non-enhanced MRI radiomics. Int. J. Hyperthermia 42(1), 2468766 (2025).","journal-title":"Int. J. Hyperthermia"},{"key":"48587_CR30","doi-asserted-by":"crossref","unstructured":"Liu, Z., Liu, Z., Wang, Y., Wan, X. & Huang, X. Machine learning-based predictive analysis of energy efficiency factors necessary for the HIFU treatment of adenomyosis. Front. Physiol.\u00a016 (2025).","DOI":"10.3389\/fphys.2025.1602866"},{"issue":"3","key":"48587_CR31","doi-asserted-by":"publisher","first-page":"e2443","DOI":"10.1097\/MD.0000000000002443","volume":"95","author":"X Liu","year":"2016","unstructured":"Liu, X. et al. Clinical predictors of long-term success in ultrasound-guided high-intensity focused ultrasound ablation treatment for adenomyosis: A retrospective study. Medicine 95(3), e2443 (2016).","journal-title":"Medicine"},{"key":"48587_CR32","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ultsonch.2016.11.022","volume":"36","author":"Y Feng","year":"2017","unstructured":"Feng, Y. et al. Safety of ultrasound-guided high-intensity focused ultrasound ablation for diffuse adenomyosis: A retrospective cohort study. Ultrason. Sonochem. 36, 139\u201345 (2017).","journal-title":"Ultrason. Sonochem."},{"key":"48587_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2022.941368","volume":"9","author":"Q Zhong","year":"2022","unstructured":"Zhong, Q. et al. Factors influencing treatment decisions in HIFU treatment of adenomyosis: A retrospective study. Front. Surg. 9, 941368 (2022).","journal-title":"Front. Surg."},{"issue":"1","key":"48587_CR34","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s00330-020-07076-1","volume":"31","author":"Z Li","year":"2021","unstructured":"Li, Z. et al. Utilization of radiomics to predict long-term outcome of magnetic resonance-guided focused ultrasound ablation therapy in adenomyosis. Eur. Radiol. 31(1), 392\u2013402 (2021).","journal-title":"Eur. Radiol."},{"issue":"10","key":"48587_CR35","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/jum.16529","volume":"43","author":"R Liu","year":"2024","unstructured":"Liu, R., Hao, H., Yin, Y., Chen, L. & Liu, Y. Effect of high-intensity focused ultrasound on different types of adenomyosis based on magnetic resonance imaging classification. J. ultrasound medicine: official J. Am. Inst. Ultrasound Med. 43(10), 1947\u20131955 (2024).","journal-title":"J. ultrasound medicine: official J. Am. Inst. Ultrasound Med."},{"issue":"1","key":"48587_CR36","doi-asserted-by":"publisher","first-page":"2211268","DOI":"10.1080\/02656736.2023.2211268","volume":"40","author":"F Xu","year":"2023","unstructured":"Xu, F. et al. Comparison of high-intensity focused ultrasound for the treatment of internal and external adenomyosis based on magnetic resonance imaging classification. Int. J. hyperthermia: official J. Eur. Soc. Hyperthermic Oncol. North. Am. Hyperth. Group. 40 (1), 2211268 (2023).","journal-title":"Int. J. hyperthermia: official J. Eur. Soc. Hyperthermic Oncol. North. Am. Hyperth. Group."},{"issue":"Suppl 1","key":"48587_CR37","doi-asserted-by":"publisher","first-page":"O95","DOI":"10.1186\/2050-5736-3-S1-O95","volume":"3","author":"H Coy","year":"2015","unstructured":"Coy, H. et al. Efficacy of MR-guided focused ultrasound ablation for localized adenomyosis in comparison to leiomyoma. J. Ther. Ultrasound. 3 (Suppl 1), O95 (2015).","journal-title":"J. Ther. Ultrasound"},{"key":"48587_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13195828","author":"A Athanasiou","year":"2024","unstructured":"Athanasiou, A. et al. Advances in adenomyosis treatment: High-intensity focused ultrasound, percutaneous microwave therapy, and radiofrequency ablation. J. Clin. Med. https:\/\/doi.org\/10.3390\/jcm13195828 (2024).","journal-title":"J. Clin. Med."},{"key":"48587_CR39","doi-asserted-by":"publisher","first-page":"106778","DOI":"10.1016\/j.crad.2024.106778","volume":"81","author":"Z Liu","year":"2025","unstructured":"Liu, Z., Liu, Z., Wan, X., Wang, Y. & Huang, X. Predicting high-intensity focused ultrasound efficacy in adenomyosis treatment based on magnetic resonance (MR) radiomics and clinical-imaging features. Clin. Radiol. 81, 106778 (2025).","journal-title":"Clin. Radiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48587-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48587-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48587-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:04:12Z","timestamp":1786539852000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48587-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["48587"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-48587-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"5 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol has been reviewed and approved by the Institutional Review Board (IRB) at Qingdao Women and Children\u2019s Hospital (No. QFELL-YJ-2024-64). I confirm that all methods were performed in accordance with the relevant guidelines. All procedures were performed in accordance with the ethical standards set out in the 1964 Declaration of Helsinki and its subsequent amendments. All patients provided clinical consent to the FUAS procedure. The ethics committee waived the requirement for individual informed consent for research purposes, given the study\u2019s retrospective nature.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"25054"}}